| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 67.350 | 50.894 | 48.803 | 63.423 | 60.790 | 67.419 | 80.275 | 84.943 | 83.979 | 87.908 |
| Total Income - EUR | 67.438 | 50.918 | 48.806 | 63.429 | 60.811 | 67.419 | 80.336 | 84.956 | 83.990 | 88.584 |
| Total Expenses - EUR | 16.517 | 19.687 | 19.853 | 25.759 | 29.456 | 26.807 | 28.581 | 30.034 | 32.510 | 40.715 |
| Gross Profit/Loss - EUR | 50.921 | 31.231 | 28.953 | 37.670 | 31.355 | 40.612 | 51.755 | 54.922 | 51.480 | 47.869 |
| Net Profit/Loss - EUR | 49.048 | 30.722 | 28.465 | 37.036 | 30.746 | 39.983 | 50.980 | 54.224 | 50.780 | 45.344 |
| Employees | 1 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
Check the financial reports for the company - Diabs&Nutricare Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.241 | 12.889 | 9.634 | 6.376 | 3.280 | 682 | 534 | 698 | 4.596 | 27.032 |
| Current Assets | 51.022 | 23.578 | 26.894 | 38.351 | 33.554 | 45.256 | 56.221 | 59.123 | 47.642 | 20.493 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 7.518 | 451 | 12.358 | 3.518 | 2.187 | 1.365 | 409 | 1.127 | 5.487 | 25 |
| Cash | 43.503 | 23.128 | 14.535 | 34.834 | 31.367 | 43.891 | 55.811 | 57.996 | 42.155 | 20.468 |
| Shareholders Funds | 48.980 | 34.756 | 28.509 | 37.079 | 30.789 | 40.024 | 51.020 | 54.273 | 50.828 | 45.393 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 3.300 | 1.729 | 8.039 | 7.669 | 6.046 | 5.935 | 5.755 | 5.589 | 1.747 | 2.775 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Diabs&Nutricare Srl